Long-term relationship between everolimus blood concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma: a prospective study

• Main Authors: Shinya Takasaki (Author), Hiroaki Yamaguchi (Author), Yoshihide Kawasaki (Author), Masafumi Kikuchi (Author), Masaki Tanaka (Author), Akihiro Ito (Author), Nariyasu Mano (Author)
• Format: Book
• Published: BMC, 2019-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Everolimus is an oral inhibitor of mammalian target of rapamycin, approved for metastatic renal cell carcinoma (mRCC). Recently, personalized medicine through therapeutic drug monitoring (TDM) is recommended in cancer therapy. In this study, the relationship between everolimus bl...